Cannabis and sleep: do THC and CBD really help?

Falling asleep is not the entire story

“I cannot sleep without cannabis” is a familiar account from some patients. A person may feel calmer, fall asleep faster and awaken less often because pain has eased. Such experiences can be meaningful, but they do not automatically prove that cannabis treats insomnia. Sleep quality depends on duration, continuity, sleep stages and daytime functioning, not only how quickly someone becomes drowsy.

Sleep cycles and endocannabinoid signaling

Normal sleep alternates between non-REM (NREM) and REM stages. Different stages relate to memory, physiology, hormonal activity and immune processes. Sleep and wakefulness are regulated by interacting neural systems. The endocannabinoid system participates in these networks, and studies have reported daily variation in endocannabinoid signaling. This provides a reason to study cannabis compounds—but their effects cannot be reduced to a single 'sleep switch.'

THC, CBD and CBN should not be treated as equivalents

THC can cause sedation in some people, depending on dose and sensitivity. CBD has a more complex profile and is not established as a straightforward natural sleeping pill. Commercial products may combine THC, CBD, CBN and terpenes; evidence from one formulation is not automatically transferable to another. A product labeled 'cannabis for sleep' may contain a very different pharmacological mixture from the product studied in a clinical trial.

What do randomized trials tell us?

A 2022 systematic review and meta-analysis of 39 randomized trials involving about 5,100 people. It found that medical cannabis and cannabinoids may provide small improvements in aspects of sleep quality, particularly among people living with chronic pain. Importantly, 33 of those 39 studies involved participants with cancer-related or other chronic pain. They were not primarily studies of uncomplicated insomnia. The improvement in sleep might partly reflect pain relief rather than a direct correction of the sleep disorder.

Insomnia itself: encouraging but limited trials

Small randomized studies have examined cannabinoid-containing oils and formulations in people with insomnia. One study included 29 people and reported improvement on some sleep measures compared with placebo. Another pilot study in 2025 included 20 adults with subthreshold insomnia symptoms and tested a combination including THC, CBD, CBN and terpenes, with improvement on selected outcomes. These findings justify more research but cannot yet support a blanket recommendation for all people with insomnia.

What about CBD on its own?

A small randomized study in 2024 examined 150 mg of CBD at night in people with moderate or severe insomnia. The overall findings were mixed and did not demonstrate that CBD alone is a proven insomnia treatment. It would also be misleading to assume a low-dose commercial bottle reproduces the effects of a research product at a very different dose. Product quality, dose and the population studied must all be considered.

REM, dreaming, tolerance and stopping use

Some regular users report fewer remembered dreams while taking THC and vivid dreams after stopping. This may reflect changes in REM sleep, but effects vary with the compound, dose and pattern of use. Repeated exposure can produce tolerance: a previously sedating dose may become less effective, tempting people to increase it. Abrupt discontinuation after regular use can cause temporary trouble falling asleep, fragmented sleep, restlessness and intense dreams. These effects may create a cycle in which withdrawal-related insomnia seems to confirm a need for more cannabis.

The link between pain and sleep

Pain can interrupt sleep, while poor sleep can increase sensitivity to pain the next day. A treatment that modestly reduces chronic pain may indirectly improve rest and perceived wellbeing. This helps explain why the evidence appears stronger in people whose sleep is disrupted by another condition than in people with primary insomnia alone. It also reminds us to investigate why a particular person is not sleeping before evaluating a substance as the answer.

Next-day effects are part of the treatment decision

The reviewed trials also reported adverse effects such as dizziness, drowsiness, dry mouth, tiredness and nausea. THC can impair alertness, reaction time and coordination after use, sometimes into the following day, especially after oral formulations. Feeling sleepy is not the same as waking refreshed and functioning safely. CBN, often advertised as a 'sleep cannabinoid', has limited independent clinical evidence when separated from other ingredients.

The bottom line

Cannabinoids may lead to small improvements in sleep outcomes for some people, especially those with chronic pain. Trials focused specifically on insomnia remain smaller and less conclusive. THC-related sedation, tolerance, withdrawal symptoms and residual impairment deserve attention; CBD alone and CBN should not be marketed as established sleep medications. The practical question is what is disrupting sleep and whether any potential benefit outweighs the risks over time.

Scientific sources

1. AminiLari M, et al. Medical cannabis and cannabinoids for impaired sleep: systematic review and meta-analysis of randomized clinical trials. Sleep. 2022.
   Find this source ↗
2. Medicinal cannabis improves sleep in adults with insomnia: randomized double-blind placebo-controlled crossover study.
   Find this source ↗
3. Cannabidiol for moderate–severe insomnia: randomized controlled pilot trial. 2024.
   Find this source ↗
4. Effectiveness of a Cannabinoids Supplement on Sleep and Mood: randomized placebo-controlled pilot trial. 2025.
   Find this source ↗
5. Acute Effects of Oral Cannabinoids on Sleep and High-Density EEG in Insomnia. 2025/2026.
   Find this source ↗
6. The role of cannabis and the endocannabinoid system in sleep regulation and cognition.
   Find this source ↗